← SynDRA
PD-168,077
SynDRA canonical compound SYN0002319 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | DRD2 | DRD4 |
| Mechanism of action | dopamine receptor agonist |
All known targets
Mechanisms of action (all sources)
- dopamine receptor agonist
- DRD2 INHIBITOR
Cross-references
Synonyms
- PD 168077
- CHEMBL45244
- N-[[4-(2-cyanophenyl)piperazin-1-yl]methyl]-3-methylbenzamide
- Benzamide, N-[[4-(2-cyanophenyl)-1-piperazinyl]methyl]-3-methyl-
- PD 168,077 maleate salt
- N-((4-(2-cyanophenyl)piperazin-1-yl)methyl)-3-methylbenzamide
- AC1MURTZ
- Tocris-1065
- NCGC00015791-01
- Lopac-P-233
- Biomol-NT_000050
- Lopac0_000969
- GTPL975
- BPBio1_001301
- SCHEMBL4002275
- DTXSID7044007
- NOCAS_44007
- CHEBI:94634
- BCP08352
- ZINC25758996
- BDBM50058225
- AKOS028108749
- CCG-205049
- NCGC00024977-02
- PD-168077
- PD 168,077
- 2A5XS99U8Q
- PD168,077
- PD168077
- RefChem:928682
- DTXCID5024007
- PD 168077 maleate
- UNII-2A5XS99U8Q
- orb1706022
- SCHEMBL29435417
- DNULYRGWTFLJQL-UHFFFAOYSA-N
- SDCCGSBI-0050942.P002
- NCGC00015791-02
- NCGC00015791-03
Look up PD-168,077 in the interactive SynDRA portal →